Hayashi N, Yagata H, Tsugawa K, Kajiura Y, et al. Response and Prognosis of Docetaxel and Cyclophosphamide as Neoadjuvant Chemotherapy in ER(+) HER2(-) Breast Cancer: A Prospective Phase II Study. Clin Breast Cancer 2020 Sep 18. pii: S1526-8209(20)30233.
PMID: 33046356